Phase 1 Study to Determine the Effect of Lenvatinib (E7080) on the Pharmacokinetics of Midazolam in Subjects With Advanced Solid Tumors
Clinical trial NCT02686164 · COMPLETED
Trial details
- NCT number
- NCT02686164
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-18
- Primary completion
- 2017-01-04
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.